Evidence map›Paper›PMID 41815201›Full record

ArticleJournal of applied glycoscience2026

Effects of D-Glucosamine on the Growth of Human Gut-Dominant Microbiota

Tomoya Shintani, Soyoka Sakiyama, Yuta Ami, Hideya Shintani, Shin Kurihara

Abstract read
In one paragraph

Article in Journal of applied glycoscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Tomoya Shintani1 Toyo Institute of Food Technology.
Soyoka Sakiyama2 Faculty of Biology-Oriented Science and Technology, Kindai University.
Yuta Ami2 Faculty of Biology-Oriented Science and Technology, Kindai University.
Hideya Shintani3 Shintani Internal Medicine and Diabetes Clinic.
Shin Kurihara2 Faculty of Biology-Oriented Science and Technology, Kindai University.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

D-Glucosamine hydrochloride (GlcN), a monomer produced by the hydrolysis of chitosan, is a dietary supplement used worldwide to mitigate cartilage degeneration. Previous reports have shown that some dietary glucosamine migrates to the colon. However, the effect of glucosamine alone on colonic microbiota and bowel movements remains poorly understood. In this study, we evaluated the effect of glucosamine on the growth of 46 dominant human colonic bacterial species and 24 other important bacteria

Indexed as

bowel movementsD-glucosaminehuman gut microbiotaopen label single arm trialprebiotics

Identifiers

PMID41815201
PMCPMC12973176

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.